659 related articles for article (PubMed ID: 16985246)
21. [Phytoestrogens].
Zittermann A
Zentralbl Gynakol; 2003 Jun; 125(6):195-201. PubMed ID: 14556117
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review.
Ricketts ML; Moore DD; Banz WJ; Mezei O; Shay NF
J Nutr Biochem; 2005 Jun; 16(6):321-30. PubMed ID: 15936643
[TBL] [Abstract][Full Text] [Related]
23. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
[TBL] [Abstract][Full Text] [Related]
24. [Soy isoflavones and human health: breast cancer and puberty timing].
Valladares L; Garrido A; Sierralta W
Rev Med Chil; 2012 Apr; 140(4):512-6. PubMed ID: 22854699
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
Bielecki A; Roberts J; Mehta R; Raju J
Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
[TBL] [Abstract][Full Text] [Related]
26. Global gene expression profiles induced by phytoestrogens in human breast cancer cells.
Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H
Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284
[TBL] [Abstract][Full Text] [Related]
27. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
Magee PJ; Rowland IR
Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
[TBL] [Abstract][Full Text] [Related]
28. Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study.
Boyapati SM; Shu XO; Ruan ZX; Dai Q; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2005 Jul; 92(1):11-7. PubMed ID: 15980986
[TBL] [Abstract][Full Text] [Related]
29. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.
Iwasaki M; Inoue M; Otani T; Sasazuki S; Kurahashi N; Miura T; Yamamoto S; Tsugane S;
J Clin Oncol; 2008 Apr; 26(10):1677-83. PubMed ID: 18316793
[TBL] [Abstract][Full Text] [Related]
30. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
31. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
Liu B; Edgerton S; Yang X; Kim A; Ordonez-Ercan D; Mason T; Alvarez K; McKimmey C; Liu N; Thor A
Cancer Res; 2005 Feb; 65(3):879-86. PubMed ID: 15705886
[TBL] [Abstract][Full Text] [Related]
32. Soy isoflavones and their bone protective effects.
Zhang Y; Chen WF; Lai WP; Wong MS
Inflammopharmacology; 2008 Oct; 16(5):213-5. PubMed ID: 18815742
[TBL] [Abstract][Full Text] [Related]
33. Phytoestrogens and the risk of breast cancer: a review of the literature.
Gikas PD; Mokbel K
Int J Fertil Womens Med; 2005; 50(6):250-8. PubMed ID: 16526415
[TBL] [Abstract][Full Text] [Related]
34. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.
Akhter M; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2128-35. PubMed ID: 18708407
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of dietary phytoestrogens in chronic renal disease.
Ranich T; Bhathena SJ; Velasquez MT
J Ren Nutr; 2001 Oct; 11(4):183-93. PubMed ID: 11679998
[TBL] [Abstract][Full Text] [Related]
36. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
37. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.
Wood CE; Register TC; Franke AA; Anthony MS; Cline JM
Cancer Res; 2006 Jan; 66(2):1241-9. PubMed ID: 16424064
[TBL] [Abstract][Full Text] [Related]
38. The effects of soy isoflavones on obesity.
Ørgaard A; Jensen L
Exp Biol Med (Maywood); 2008 Sep; 233(9):1066-80. PubMed ID: 18535167
[TBL] [Abstract][Full Text] [Related]
39. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats.
Phrakonkham P; Chevalier J; Desmetz C; Pinnert MF; Bergès R; Jover E; Davicco MJ; Bennetau-Pelissero C; Coxam V; Artur Y; Canivenc-Lavier MC
Toxicol Appl Pharmacol; 2007 Oct; 224(2):105-15. PubMed ID: 17655901
[TBL] [Abstract][Full Text] [Related]
40. Soy foods, isoflavones, and the health of postmenopausal women.
Messina M
Am J Clin Nutr; 2014 Jul; 100 Suppl 1():423S-30S. PubMed ID: 24898224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
